CD24 and myeloid sarcoma: In a multiple sclerosis (MS) mouse model (experimental autoimmune encephalomyelitis; EAE), CD24 expression on CNS resident lymphocytes facilitated disease development and increased the severity of the disease [11,12], whereas CD24 knockout mice were resistant to EAE induction [12].